The four teams that previously reported directly to the chief executive officer -- two Business Development and two Marketing & Sales -- will now report to Mr. Tam. In his new role he will be responsible for all commercial activities, from early stage to commercial supply, as well as customer services. Mr. Tam will report directly to chief executive officer Gabriel Haering and will continue his current activities as director Business Development.
“This structural change was required due to company growth and the increasing complexity of commercial relations in the different geographic areas where Cerbios is active,” said Mr. Haering. “This is also part of the long-term organizational strategy of Cerbios, that integrates all our activities in a leaner structure, creating value for our partners.”
Mr. Tam has been active in the pharmaceutical industry since 1998. In 2000 he joined the Italian subsidiary of Mitsubishi Chemical Corporation Group as R&D scientist achieving the position of R&D manager. In 2005, he joined Antibioticos Marketing & Sales Department, managing special projects and custom projects with key accounts. From 2007 to 2012 he served at Recordati S.p.A. as manager Business Development in the Pharmaceutical Chemicals Division, with world-wide responsibility, and then as BD Manager at Farmabios. He joined Cerbios in 2012 as director Business Development, taking care of Cerbios’ contract manufacturing activities.